BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Canonica GW, Colombo GL, Rogliani P, Santus P, Pitotti C, Di Matteo S, Martinotti C, Bruno GM. Omalizumab for Severe Allergic Asthma Treatment in Italy: A Cost-Effectiveness Analysis from PROXIMA Study. Risk Manag Healthc Policy 2020;13:43-53. [PMID: 32158289 DOI: 10.2147/RMHP.S211321] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Di Bona D, Spataro F, Carlucci P, Paoletti G, Canonica GW. Severe asthma and personalized approach in the choice of biologic. Current Opinion in Allergy & Clinical Immunology 2022;22:268-275. [DOI: 10.1097/aci.0000000000000829] [Reference Citation Analysis]
2 Hasan SS, Capstick T, Zaidi STR, Kow CS, Merchant HA. Use of corticosteroids in asthma and COPD patients with or without COVID-19. Respir Med 2020;170:106045. [PMID: 32843175 DOI: 10.1016/j.rmed.2020.106045] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 6.7] [Reference Citation Analysis]